StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Viridian Therapeutic (VRDN) PT Lowered to $32 at Evercore ISI
April 2, 2026 5:14 AM
Evercore ISI analyst Gavin Clark-Gartner ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
RBC: 'we expect to see a negative impact to VRDN's shares', Shares 24% Today
April 6, 2026 11:45 AM